Apollomics: LaunXP Payment Still Pending
Ticker: APLMW · Form: 6-K · Filed: Oct 21, 2025 · CIK: 1944885
| Field | Detail |
|---|---|
| Company | Apollomics Inc. (APLMW) |
| Form Type | 6-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $3,900,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: update, payment-issue, partnership
TL;DR
Apollomics' partner LaunXP still hasn't paid up as of Oct 21, 2025.
AI Summary
Apollomics Inc. filed a 6-K on October 21, 2025, providing an update on its agreement with LaunXP International Co., Ltd. The filing states that LaunXP has not yet fully satisfied its payment obligations as previously disclosed in a July 25, 2025 6-K filing.
Why It Matters
This filing indicates a potential ongoing financial issue with a key partner, which could impact Apollomics' financial stability and operational plans.
Risk Assessment
Risk Level: medium — The company is highlighting a partner's failure to meet payment obligations, which introduces financial and operational uncertainty.
Key Players & Entities
- Apollomics Inc. (company) — Filer of the 6-K report
- LaunXP International Co., Ltd. (company) — Partner with outstanding payment obligations
- July 25, 2025 (date) — Date of previous 6-K filing disclosing payment issue
- October 21, 2025 (date) — Filing date of the current 6-K report
FAQ
What specific payment obligations has LaunXP International Co., Ltd. failed to satisfy?
The filing does not specify the exact nature or amount of the outstanding payment obligations, only that they have not been fully satisfied.
When was the initial disclosure of LaunXP's payment issue made?
The initial disclosure was made in Apollomics' Form 6-K filed on July 25, 2025.
What is the current status of the agreement between Apollomics and LaunXP?
The filing indicates that LaunXP has not fully satisfied its payment obligations under the agreement, suggesting the agreement is not yet fully executed from a payment perspective.
Does this filing provide a timeline for when LaunXP is expected to fulfill its payment obligations?
No, the filing does not provide any specific timeline or expected date for LaunXP to satisfy its payment obligations.
What are the potential consequences for Apollomics if LaunXP continues to not satisfy its payment obligations?
The filing does not explicitly state the consequences, but failure to receive payments could impact Apollomics' financial resources and operational capabilities.
Filing Stats: 379 words · 2 min read · ~1 pages · Grade level 11.8 · Accepted 2025-10-21 11:13:07
Key Financial Figures
- $3,900,000 — ny has recently received a payment of US$3,900,000 from LaunXP. The Agreement remains in f
Filing Documents
- d20232d6k.htm (6-K) — 13KB
- 0001193125-25-244493.txt ( ) — 14KB
From the Filing
6-K OMB APPROVAL OMB Number: 3235-0116 Expires: December 31, 2026 Estimated average burden hours per response 8.7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2025. Commission File Number 001-41670 Apollomics Inc. Not Applicable (Translation of registrant's name into English) 989 E. Hillsdale Blvd., Suite 220, Foster City, California 94404 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-FForm 40-F Update on the Agreement with LaunXP Pursuant to the Company's Form 6-K filed on July 25, 2025 (the "July 2025 6-K"), Apollomics Inc. ("Apollomics" or the "Company") previously disclosed that LaunXP International Co., Ltd. ("LaunXP") had not fully satisfied its payment obligations under its agreement with the Company for the development and commercialization of vebreltinib in Asia (excluding mainland China, Hong Kong and Macau) (the "Agreement"). As a result, the Company disclosed that it had notified LaunXP of such breach and that the parties were engaged in discussions to resolve the matter. By way of update to the disclosure contained in the Company's Form 6-K filed in July 2025, Apollomics hereby reports that, in connection with the previously disclosed transaction, the Company has recently received a payment of US$3,900,000 from LaunXP. The Agreement remains in full force and effect, and both parties continue to perform their respective obligations and maintain active discussions to advance the ongoing collaboration under the Agreement. The information in this Form 6-K regarding the Agreement with LaunXP is incorporated by reference into the Company's registration statements under the Securities Act, including its registration statements on Form S-8 (File No. 333-272559) and Form F-3 (File Nos. 333-278430, 333-278431 and 333-279549), and shall be a part thereof, to the extent not superseded by documents or reports subsequently filed or furnished. 2 of 3 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. APOLLOMICS INC. (Registrant) Date October 21, 2025 /s/ Peter Lin Peter Lin, Chief Financial Officer 3 of 3